Top Tech Companies in Boston, MA (4,697)

Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.

Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.

Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.

Strong Revenue Growth: Revenue is rising at a double-digit pace, with FY2025 up about 32% to $1.234B and Q1–Q2 2026 growing roughly 28% and 26% year over year, alongside raised FY2026 guidance implying around 24% growth. Larger-account cohorts also expanded materially, reinforcing the top-line trajectory.

Customer Loyalty & Retention: Dollar-based net revenue retention was approximately 109–110%, indicating existing customers are expanding spend on the platform. Higher-value segments grew quickly as well, including customers generating over $50K in ARR rising in the mid-to-high 30% range year over year.

Market Expansion: International revenue is outpacing overall growth, including 42% growth in FY2025 and mid-30% growth in early 2026. Total customers also surpassed 205,000 globally as enterprise and multi-product adoption broadened.

Resilient & Sustainable Growth: Revenue has increased year over year to a new high, with all three major service lines posting gains despite a slower pace. Growth remains uneven by region, but the overall trajectory is upward over the last several fiscal years.

Future-Ready Strategy: Multi‑billion‑dollar investments in technology—especially nearly $1.5B in AI—along with acquisitions and scaling managed services indicate a deliberate pivot to future growth levers. Leadership attention to next‑generation audit and AI‑enabled capabilities underscores preparation for emerging demand.

Strong Market Position & Advantage: The organization is characterized as a leading global professional‑services network with broad scale across assurance, advisory, and tax and repeated external recognitions in select consulting categories. Reach across major multinational clients supports durable competitive positioning.

Customer Loyalty & Retention: Autoship accounts for the vast majority of sales (over four-fifths) and is growing faster than total revenue, indicating a sticky, recurring base and higher retention. Evidence includes Autoship representing ~83% of FY2025 net sales and ~84.6% in Q2 FY2026 with high single‑digit to double‑digit growth.

Profitability: Operating metrics show expanding earnings power, with adjusted EBITDA up materially and margins improving alongside strong free cash flow. Observations include FY2025 adjusted EBITDA growth of ~26% with margin expansion and additional year‑over‑year gains reported in 1H FY2026.

Strong Market Position & Advantage: Chewy is characterized as the largest U.S. pet e‑tailer and a leading online pet‑supplies platform by GMV and digital presence, underpinning durable scale advantages. Multiple summaries highlight leadership in online pet retail, substantial Autoship penetration, and strong digital search share versus specialty peers.

Strong Revenue Growth: UK company filings indicate revenue rose from about £169.4m in 2023 to £197.0m in 2024, evidencing clear double-digit growth. Parent-company reporting in 2025 also attributed an increase in its ‘Other revenues’ to growth in Simply Business.

Profitability: Operating profit reportedly increased from roughly £24.2m to £45.9m in 2024, rising far faster than revenue. This points to improving margins and efficiency alongside scale.

Market Expansion: The business surpassed one million customers globally in 2024 and later reached one million in the UK, with continued activity in the U.S. and new partnerships and office investments. These milestones suggest ongoing expansion of reach and channels.

Strong Revenue Growth: Revenue is reported to have expanded dramatically over a recent three-year period, earning recognition on a leading high-growth list. Feedback suggests this reflects substantial commercial traction rather than growth based solely on financing.

Strong Market Position & Advantage: Customer adoption spans 500+ MedTech companies, including deep penetration among the largest enterprises (e.g., 16 of the top 20). Feedback suggests this breadth and upmarket presence signal durable positioning within its niche.

Investor Backing & Capital Strength: Capital raised has surpassed $160M with a recent late-stage round and a valuation near the unicorn threshold. Feedback suggests this funding base supports continued product expansion, AI initiatives, and go-to-market scale.

Product Line Growth: Active ETFs are expanding, with MFS entering the U.S. ETF market in late 2024 and generating about $1.2B of net inflows and over $1.4B in AUM by year‑end 2025. The lineup continued to scale in 2026 with additional active ETF launches.

Strong Market Position & Advantage: Scale remains substantial, with AUM around $651.4B at year‑end 2025 and generally in the $640–$660B range through mid‑2026. Company materials also cite a top‑10 standing among U.S. active long‑term mutual fund and ETF managers.

Profitability: Earnings resilience is evident as higher average net assets supported slightly higher earnings and an improved pre‑tax operating margin in Q2 2026. This points to operational strength even amid flow headwinds.

Strong Revenue Growth: ARR increased from $177M in 2024 to $218M in 2025, with reported ARR roughly doubling since 2021. Platform activity also expanded as GMV rose from $11.2B to about $14.6–$15B over the same period.

Profitability: The group was profitable throughout 2025, following earlier profitability in the core Platform business. This progression indicates improving operating leverage alongside continued expansion.

Diversified Revenue Streams: Newer products are contributing incremental revenue, with Mirakl Connect generating about $11.7M ARR in under a year and Mirakl Ads seeing a sharp rise in ad spend in 2025. Customer additions (45 global enterprises in 2025) and launches across marketplace and dropship broaden the commercial base.

Strong Revenue Growth: ARR is described as growing over 50% annually for the past three years, and earlier disclosures cite a 522% ARR increase and 407% customer growth over four years. Directional third-party tracking also shows new-customer activity as recently as March 2026.

Profitability: The business is characterized as cash-flow positive and profitable while growing organically without outside financing. This indicates an ability to fund operations and expansion from internal performance.

Customer Loyalty & Retention: Recent case studies describe customers expanding adoption across additional business units and use cases after initial deployment. Such within-account growth signals stickiness among existing customers.

Profitability: Bottom-line performance is strengthening, with consistent earnings beats, improved non-GAAP operating income, and durable free cash flow. Management is prioritizing margin expansion alongside operational efficiency.

Healthy Cash Flow: The business is generating solid free cash flow, with recent periods and guidance pointing to sustained cash generation. This supports stability even as revenue growth moderates.

Strong Market Position & Advantage: The company is repeatedly recognized as a leader in MDR, exposure management, and SIEM by major analyst programs. A large global customer base underscores established scale in its core markets.

Profitability: Net income rose to $6.79B in 2025 from $4.38B in 2024. The combined ratio improved materially (e.g., S&P-adjusted 89.7% in 2025 and high-80s in early 2026), indicating stronger underwriting performance.

Investor Backing & Capital Strength: Shareholders’ equity increased from about $22.2B in 2022 to $39.9B at year-end 2025 and exceeded $44B by mid-2026. External ratings actions (AM Best A affirmation in Sept 2025; S&P upgrade to A+ in July 2026) underscore improved capitalization.

Resilient & Sustainable Growth: S&P describes deliberate portfolio reshaping and expects 2–3% annual premium growth during 2026–2028. Management emphasizes disciplined, selective expansion following underwriting improvements, prioritizing durable returns over sheer volume.

Investor Backing & Capital Strength: Funding reached a $200M Series C in July 2024 at a $1B valuation with prominent investors. Available evidence suggests substantial capital to scale and strong external confidence.

Market Expansion: Engagements extended across governments and enterprises, including the UK’s £8M three-year program, a CBP contract expansion, and new deployments with General Atomics Aeronautical Systems and Scarbrough Global; by 2026, the company said 8 of the world’s 10 largest logistics providers were customers. These signals indicate continued penetration into large, international accounts and public-sector programs.

Product Line Growth: The offering broadened beyond supply-chain mapping into compliance, procurement, trade-risk management, and customs-automation workflows, including the 2026 Cervo AI acquisition. 2025–2026 materials describe additional use cases and live customer deployments.

Strong Market Position & Advantage: Ekotrope is positioned as the most widely used HERS rating software in the U.S., supporting roughly 1 in 4 new homes and serving 7,000+ builders with 400,000+ homes per year. Penetration spans hundreds of HERS rating companies and more than 40 utility new‑construction programs.

Investor Backing & Capital Strength: An $11M financing in October 2025, bringing tracked cumulative funding to about $15.9M, underscores continued capital support for expansion. Multiple independent profiles indicate the company has raised additional capital over time rather than a single one‑off event.

Product Line Growth: The company has expanded beyond its core RATER tool into Market Intelligence data products and solutions for utilities, builders, manufacturers, and lenders. Release history shows major version updates (e.g., Version 5.0 in 2025 with additional releases in 2026), indicating an active roadmap.

Strong Revenue Growth: Evidence indicates revenue grew rapidly over the period recognized by Deloitte’s 2025 Technology Fast 500, with earlier multi‑year gains also cited. Consecutive Fast 500 placements suggest sustained top‑line momentum.

Market Expansion: The company reports 130+ customers, including 13 of the top 30 P&C carriers, and moved to a much larger Boston headquarters. Customer counts have increased markedly since earlier periods, indicating broader market reach.

Product Line Growth: Materials describe expansion beyond claims into policyholder service and the launch of Unite to connect carriers with service providers. These additions broaden use cases and deepen penetration within carriers.

Strong Revenue Growth: Company updates describe double-digit revenue growth in 2024, back-to-back record years, and roughly 30% year-over-year new-business growth across 2024–2025. Momentum is further indicated by reported acceleration in cloud/SASE/microsegmentation activity.

Customer Loyalty & Retention: Customer net retention of 107% in 2025 suggests expansion within the existing base. This points to durable relationships with large enterprises across multiple industries.

Product Line Growth: The portfolio expanded via the 2024 acquisition of AKIPS and the addition of AI-driven capabilities, extending from policy management into broader network visibility and operations. Growth in cloud, SASE, and microsegmentation (reported at 2.5× in 2025) illustrates traction for newer offerings.

Investor Backing & Capital Strength: Multiple funding rounds, including $8.2M in 2020, a $20M Series A in 2021 at a reported $100M valuation, and a $17M investment in 2026 from Enlightened Hospitality Investments, indicate strong capital support. The 2026 round is tied to product/engineering investment and go-to-market expansion.

Market Expansion: Customer reach spans hospitality, retail, transportation, healthcare, manufacturing, and logistics, with deployments cited across 32 countries and large-scale rollouts at brands such as McDonald’s and Elara Caring. A 2026 global partnership with Shake Shack and the addition of 700,000+ hospitality users in 2025 underscore geographic and vertical growth.

Strong Revenue Growth: ARR reportedly increased from $200K (Apr 2019) to $5M (Feb 2023), and U.S. growth of 159% was reported for fiscal 2023. These signals point to substantial revenue momentum even though more recent ARR figures are not disclosed.

Strong Revenue Growth: Revenue is scaling at strong double-digit rates, reaching $702M in FY2026 and continuing to rise in subsequent quarters, with full‑year FY2027 guidance lifted into the low‑$900M range. Multiple updates indicate momentum in both reported results and outlook.

Healthy Cash Flow: Operating cash flow turned positive in FY2026 and free cash flow was also positive, alongside progress in non‑GAAP profitability in later quarters. These milestones suggest improving financial efficiency as scale increases.

Diversified Customer Base: The company reports 12,500+ active customers and continued wins with large enterprises across technology, manufacturing, and healthcare. This breadth points to demand resilience across multiple industries.

Strong Revenue Growth: Company disclosures cite strong year-over-year revenue growth in 2025 with annualized revenue surpassing $300M, and later coverage describes revenue nearing $400M annualized in 2026. This points to rapid scaling from 2023 through 2026.

Investor Backing & Capital Strength: Recent financings include a $200M Series E at a $2.7B valuation and a $300M private credit facility, with third-party trackers noting over $1B raised across multiple rounds. This capital base is positioned to fund continued product and geographic expansion.

Market Expansion: The company launched its Spend product in the U.S. and indicated the market already represents a substantial share of new business, while also opening new international locations. These moves signal broadening global reach and demand.

Profitability: Square gross profit increased year over year in 2025 and again in recent quarters, with gains driven by processing, software, and financial solutions like Square Loans. Filings indicate this momentum continued into 2026, with growth excluding hardware also improving.

Strong Market Position & Advantage: Square is described as a leader in small-business POS and commerce, serving millions of sellers and processing a very large volume of payments. Industry recognition and scale suggest durable competitive positioning in its core segments.

Market Expansion: International payment volume is growing faster than the U.S., and sectors such as food and beverage led recent gains. Seller acquisition accelerated late in 2025, indicating widening reach across geographies and customer segments.

Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.

Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.

Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.